Skip to content
Screener

Roivant Sciences ROIV Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Moderna logo
ModernaMRNA
$697M-7.1%
Regenxbio logo
RegenxbioRGNX
$43.87M-13.1%
Revvity logo
RevvityRVTY
$163.25M-6.0%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
10.1%-0.6pp

Other financials

Income statement

See full
Revenue$1.4M-33.5%
Operating income-$366.0M-28.5%
Net income-$189.8M+15.0%
EPS (diluted)-$0.26+21.2%

Balance sheet

See full
Cash & equivalents$77.1M-18.7%
Total debt$107.2M+7.5%
Total equity$4.2B-2.6%
Total assets$5.3B+5.4%

Cash flow

See full
Operating cash flow-$270.5M-32.4%
CapEx$419.0K-89.6%
Free cash flow-$270.9M-30.0%

Valuation

See full
Market cap$25.37B+219%
Enterprise value$25.4B+219%
P/S3,368×+3,026×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp
FCF margin-10,901%-22,382pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0.0×
Current ratio16.7×-23.8×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Roivant Sciences’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:28 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q2 2026
Accession
0001635088-26-000090
Line itemJune 30, 2026March 31, 2026
Other current assets128,371105,316
Total current assets4,742,0805,167,384
Property and equipment, net11,32011,986
Operating lease right-of-use assets78,88680,416
Investments measured at fair value444,622407,985
Other assets29,58540,916
Total assets$5,306,493$5,708,687
Liabilities and Shareholders’ Equity

Item 1. Financial Statements (Unaudited).

FAQ

What is Roivant Sciences's operating lease ROU assets?
Roivant Sciences (ROIV) reported operating lease ROU assets of $78.89M in Q2 2026.
How has Roivant Sciences's operating lease ROU assets changed year-over-year?
Roivant Sciences's operating lease ROU assets decreased by 9.4% year-over-year, from $87.08M to $78.89M.
What is the long-term trend for Roivant Sciences's operating lease ROU assets?
Over 5 years (2020 to 2025), Roivant Sciences's operating lease ROU assets has grown at a 5.2% compound annual growth rate (CAGR), from $62.28M to $80.42M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Roivant Sciences's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude